Outpatient Laboratory Monitoring for Antibiotic-related Adverse Events in Children With Acute Hematogenous
Felicia O Rosiji1, Marritta Joseph, Lauren M Sommer
1From the Division of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas.
Abstract:
Monitoring for antibiotic-related lab abnormalities (ARLA), including hematologic, renal, and/or hepatic toxicity, in pediatric osteomyelitis is common. In 240 cases of osteomyelitis with outpatient laboratory monitoring, ARLA occurred in 13.3% with the most common finding being neutropenia. ARLA impacted antibiotic therapy in <1% of subjects, however, raising questions about the value of such monitoring being performed routinely.
Insights
Routine monitoring for antibiotic-related lab abnormalities in pediatric osteomyelitis is common. However, these abnormalities rarely impact treatment, questioning the routine value of such pediatric lab monitoring.
Area of Science:
- Pediatric infectious diseases
- Clinical pharmacology
- Laboratory medicine
Background:
- Antibiotic-related lab abnormalities (ARLA) are frequently monitored in pediatric osteomyelitis cases.
- Common toxicities include hematologic, renal, and hepatic effects.
Purpose of the Study:
- To evaluate the incidence and clinical significance of ARLA in children with osteomyelitis undergoing outpatient monitoring.
- To assess the impact of ARLA on antibiotic treatment decisions in this population.
Main Methods:
- Retrospective analysis of 240 pediatric osteomyelitis cases with outpatient laboratory monitoring.
- Documentation of ARLA occurrences, specific abnormalities (e.g., neutropenia), and impact on antibiotic therapy.
Main Results:
- ARLA were observed in 13.3% of patients.
- Neutropenia was the most frequent laboratory abnormality detected.
- ARLA led to changes in antibiotic therapy in less than 1% of cases.
Conclusions:
- While ARLA occur in a notable percentage of pediatric osteomyelitis patients, their clinical impact on antibiotic therapy is minimal.
- The routine use of extensive laboratory monitoring for ARLA in pediatric osteomyelitis warrants re-evaluation due to low clinical significance.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Urine Studies II: Urine Culture and Sensitivity Test
Acute Kidney Injury IV: Diagnostic Studies and Prevention


